Latest News and Press Releases

ROCKVILLE, Md., July 27, 2011 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) will report its second quarter 2011 financial results on Wednesday, August 3, 2011, after the market close. The...

ROCKVILLE, Md., July 18, 2011 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that NicVAX® (Nicotine Conjugate Immunotherapeutic) did not meet its primary endpoint in...

ROCKVILLE, Md., May 10, 2011 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that Dr. Raafat Fahim, President and Chief Executive Officer, will present at Noble Financial...

ROCKVILLE, Md., May 5, 2011 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its first quarter financial results for the three month period ended March 26, 2011. The Company...

ROCKVILLE, Md., April 27, 2011 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that it has completed the Phase I trial for two of the PentaStaphTM antigens that began in...

ROCKVILLE, Md., April 25, 2011 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its first quarter 2011 financial results on Thursday, May 5, 2011, after...

ROCKVILLE, Md., March 22, 2011 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that its 2011 Annual Meeting of Shareholders will be held on Wednesday, May 25, 2011 at 10:00...

ROCKVILLE, Md., March 8, 2011 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced fourth quarter and year-end financial results for the three and twelve month periods ended...

ROCKVILLE, Md., March 1, 2011 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its 2010 fourth quarter and full-year financial results on Tuesday, March 8,...

ROCKVILLE, Md., Feb. 7, 2011 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that Dr. Raafat Fahim, President and Chief Executive Officer will present at the 13th Annual BIO...